The Promise of Neuroimmune Targets for Treating Drug Addiction and Other Psychiatric Disorders: Granulocyte-Colony Stimulating Factor Exemplification

• Mehdi Farokhnia,
• Mehdi Farokhnia,
• Mehdi Farokhnia,
• Anthony L. Berger,
• Hollis C. Karoly,
• Lara S. Hwa,
• Florence P. Varodayan

Affiliations

Mehdi Farokhnia

Clinical Psychoneuroendocrinology and Neuropsychopharmacology Section, National Institute on Drug Abuse Intramural Research Program and National Institute on Alcohol Abuse and Alcoholism Division of Intramural Clinical and Biological Research, National Institutes of Health, Bethesda, MD, United States

Mehdi Farokhnia

Center on Compulsive Behaviors, National Institutes of Health, Bethesda, MD, United States

Mehdi Farokhnia

Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, United States

Anthony L. Berger

Department of Neurology, University of California San Francisco, San Francisco, CA, United States

Hollis C. Karoly

Institute for Cognitive Science, University of Colorado Boulder, Boulder, CO, United States

Lara S. Hwa

Bowles Center for Alcohol Studies, University of North Carolina School of Medicine, Chapel Hill, NC, United States

Florence P. Varodayan

Behavioral Neuroscience Program, Department of Psychology, Binghamton University-SUNY, Binghamton, NY, United States